By Anne Urda ( September 17, 2007, 12:00 AM EDT) -- Already facing a mountain of suits over Fosamax, Merck has protested a recent bid for certification of a dental monitoring class for patients taking the osteoporosis drug, arguing that the group has been unable to make a case that would justify the move....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.